Artemisia obtusiloba var. glabra
Artemisia obtusiloba var. glabra · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Artemisia obtusiloba var. glabra is a distinctive botanical variety that has garnered significant scientific interest due to its unique medicinal properties. Researchers have identified this plant as a potent source of the bioactive compound known as arglabin. This specific chemical is highly regarded for its remarkable antitumor activities within various biological studies. By investigating its pharmacological potential, scientists aim to harness the plant's natural defenses against malignant cell growth. Consequently, this species represents a promising subject in the ongoing search for novel cancer therapeutics.
- Synonyms
- Artemisia Obtusiloba Var. Glabella · Artemisia Glabella
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Artemisia obtusiloba var. glabra is a botanical taxon that is frequently identified through various nomenclature variations. Within scientific literature, it is recognized by the synonym Artemisia glabella. Additionally, researchers often refer to this specific variety using the name Artemisia obtusiloba var. glabella. These synonymous designations serve to clarify the plant's classification within the complex Artemisia genus. Understanding these overlapping names is essential for ensuring accuracy in botanical studies and field identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Artemisia obtusiloba var. glabra is a distinctive botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Asterales, showcasing its specific evolutionary lineage. As a member of the family Asteraceae, it shares characteristics with many well-known flowering plants. Ultimately, this variety is defined by its placement within the genus Artemisia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Artemisia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Artemisia obtusiloba var. glabra is a plant species primarily distributed throughout the temperate regions of Asia. Its natural range extends across the vast landscapes of Central Asia, including significant populations in Kazakhstan. The species is also widely found within China, specifically documented in the Xinjiang region. Furthermore, it inhabits the territories of Mongolia and stretches into the Altay region of Siberia. This diverse geographic spread highlights the plant's ability to thrive across various temperate ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Artemisia obtusiloba var. glabra serves as a vital source of the sesquiterpene gamma-lactone known as arglabin. Researchers have successfully modified this natural compound into Arglabin-DMA to enhance its water solubility for medical use. This derivative functions as a potent farnesyltransferase inhibitor by competitively blocking the binding of farnesyl diphosphate. Extensive in vitro studies demonstrate that the substance effectively inhibits the proliferation of various human tumor cell types. Consequently, Arglabin-DMA shows significant antitumor activity and holds promise for treating Ras-related malignancies.
Compounds
Artemisia obtusiloba var. glabra is a unique species of wormwood endemic to the Karaganda region of Kazakhstan. This plant serves as the natural source for the isolation of arglabin, a potent sesquiterpene gamma-lactone. Scientific research has focused on this compound due to its significant ability to inhibit farnesyltransferase, which prevents the post-translational modification of ras proteins. Furthermore, arglabin has demonstrated impressive anti-inflammatory properties by inhibiting the NLRP3 inflammasome and the production of proinflammatory cytokines. These diverse pharmacological characteristics suggest that derivatives of the compound hold great therapeutic potential for treating both various malignancies and cytokine storms.
Conditions
Artemisia obtusiloba var. glabra contains the natural sesquiterpene arglabin, which shows therapeutic potential in treating the cytokine storm associated with COVID-19. By inhibiting the NLRP3 inflammasome and the production of proinflammatory cytokines, this plant derivative can help attenuate inflammasome-induced ARDS. Furthermore, derivatives of this compound demonstrate significant antitumor activity against various cancers, including breast, colon, ovarian, and lung malignancies. Specifically, the water-soluble derivative Arglabin-DMA inhibits the farnesylation of H-ras and K-ras proteins. These unique pharmacological properties make the plant's compounds suitable candidates for the treatment of ras-related malignancies.